Breeze Holdings Acquisition Corp. reported that its warrants and rights will transition to the OTCQB market on June 16, 2025, after failing to meet OTCQX requirements by the March 17 deadline; the company's common stock will remain on the OTCQX. They continue plans for a business combination with YD Biopharma Limited.